Month: February 2025

Radiation for prostate cancer can come with long-term sexual side effects that aren’t always discussed upfront. While erectile dysfunction is well known, new research highlights issues with ejaculation, including reduced volume and discomfort. Patients deserve full transparency about these risks before choosing treatment. Learn why informed decision-making is crucial. keep reading

For men considering SBRT for prostate cancer, new research offers good news—this advanced radiation therapy not only reduces side effects but also lowers the risk of secondary cancers. With its targeted approach, SBRT is less likely to lead to the kind of side effects that reduce quality of life after treatment, compared to other methods of radiation treatment. keep reading

Your internal clock does more than regulate sleep—it plays a crucial role in prostate health. Research links circadian rhythm disruption to increased prostate cancer risk by affecting immune function and gene regulation. Whether it’s shift work, aging, or lifestyle habits, preserving your natural sleep cycle could be a key step in prevention. keep reading

In the world of prostate cancer (PCa), there is a dangerous cell pattern called cribriform (pronounced crib’ ri-form) or simply Cr. It has a distinctive appearance that looks similar to a sieve or a plate with lots of holes. Cr is associated with aggressive Gleason grade 4 cancer. Also, there is another PCa type called keep reading

New research reveals that liquid biomarkers—measured through simple blood and urine tests—are revolutionizing prostate cancer care. By detecting disease progression early, they help prevent overtreatment and ensure timely, targeted therapies for metastatic cases. Discover how these cutting-edge tests are reshaping prostate cancer care. keep reading

We’ve posted numerous blogs on the contributions of Artificial Intelligence (AI) to various aspects of MRI detection and diagnosis of prostate cancer (PCa). We’ve reported AI’s ability to predict metastasis, assign Gleason scores and PI-RADS scores, pinpoint tumor margins for focal therapy, rule out need for biopsy, predict PCa metastasis, and more—showing the accuracy and keep reading

There are many areas in life where high scores matter. Team sports rely on points to determine winners. Scores on achievement tests can determine if applicants are accepted into their first choice of college or university. Individual performance scores in Olympic events raise hopes of earning a gold medal. However, there’s a new kid in keep reading

It’s not exactly the ultimate “American Dream” but it’s great news for clarifying a suspicious PSA test result. As we know, the PSA blood test is controversial as a screening tool for prostate cancer (PCa) because an unexpectedly high result can mean any number of things, not just PCa. And yet, on the chance that keep reading

We’ve come a long way in focal therapy in the years since we published the blog below. Dr. Hash Ahmed’s 2014 published paper, as cited in the original blog, summarized compelling data that showed great promise for focal prostate cancer (PCa) treatment. Now, nearly a decade later, four authors from UCLA list several treatment methods with result statistics. Methods include... keep reading

One of the traits of highly successful people is their ability to stay grounded in the present moment yet anticipate the future. Although no one can predict the future with 100% accuracy, knowing the odds are favorable is a definite advantage. For prostate cancer patients, the most common treatment recommendation is radical robotic prostatectomy (RRP). In fact... keep reading